Aureon Biosciences Billing Process
Below is a brief overview of our billing process. There are two documents that are sent to the patient at the time that we bill their insurance, mostly to make sure that they understand the process and reach out to Aureon with questions rather than your office.
Our billing dept does not invoice patients directly except in the following circumstances:
1- The patient got directly reimbursed for Aureon’s services (usually happens with BCBS) and needs
to send the money to Aureon
2- The patient has a co-insurance due after we have gotten final payment from the insurance company
3- The patient has a deductible after we have gotten final payment from the insurance company
If a patient is questioning you about an unusual invoice that was received please refer them to us at 888 797-7284. It is most likely an EOB or our welcome letter not an invoice from Aureon that the patient received.The EOB could show an amount uncovered by insurance and put it under patient responsibility. Again we would not invoice the patient- we appeal the decision- several times. This most likely affects CPT code 88399.
Also, we do not balance bill patients. We accept the in-network allowable amounts from the insurance company. Lastly, we do not ask for an ABN to be signed.
The Billing dept does offer an up-front benefit investigation if required to get general info regarding deductibles and coinsurance. Again you can use the 888 797-7284 number for that service. We use the APCP (Aureon Patient Care Program) brochure and the patient welcome letter to assure the patient that Aureon is keeping their out of pocket costs in mind as we establish our new technology with payers!
Thank you for your interest and please call me, your SAE, or the billing dept directly for further questions.
Sincerely,
Billing Manger
Aureon Biosciences is a life science company founded in 2002, dedicated to enabling the advancement of predictive and personalized cancer treatment options. Aureon employs a unique Systems Pathology approach and provides personalized test results by analyzing a patient’s biopsy sample using molecular diagnostics, sophisticated tissue-based image analysis and advanced mathematics. The resulting information is objective, predictive, personalized, and allows the patient and the doctor to make more informed treatment decisions.
28 WELLS AVENUE YONKERS-NEW YORK 10701- 914-377-4000
WWW.AUREON.COM